FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22368011000001104: Selincro 18mg tablets (Lundbeck Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73801401000001117 Selincro 18mg tablets (Lundbeck Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73801501000001118 Selincro 18mg tablets (Lundbeck Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selincro 18mg tablets (Lundbeck Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Is a Nalmefene 18mg tablets true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has specific active ingredient Nalmefene hydrochloride true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nalmefene true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Is a Selincro true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has basis of strength substance Nalmefene true Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) Has active ingredient Substance with opioid receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Selincro 18mg tablets (Lundbeck Ltd) 14 tablet Has AMP True Selincro 18mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Selincro 18mg tablets (Lundbeck Ltd) 28 tablet 2 x 14 tablets Has AMP True Selincro 18mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start